BBA
NVAX icon

Baker Bros. Advisors’s Novavax NVAX Stock Holding History

Baker Bros. Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-48,168
Closed -$3.55M – 121
2022
Q1 		$3.55M Hold
48,168
– – 0.02% 94
2021
Q4 		$6.89M Sell
48,168
-60,588
-56% -$10.4M 0.03% 87
2021
Q3 		$22.5M Sell
108,756
-35,000
-24% -$7.71M 0.1% 58
2021
Q2 		$30.5M Hold
143,756
– – 0.13% 54
2021
Q1 		$26.1M Sell
143,756
-25,950
-15% -$5.17M 0.11% 57
2020
Q4 		$18.9M Sell
169,706
-17,670
-9% -$1.88M 0.07% 59
2020
Q3 		$20.3M Sell
187,376
-54,000
-22% -$6.58M 0.08% 53
2020
Q2 		$20.1M Buy
+241,376
New +$9.23M 0.09% 49
2019
Q1 		– Sell
-235,916
Closed -$8.68M – 97
2018
Q4 		$8.68M Hold
235,916
– – 0.07% 48
2018
Q3 		$8.87M Buy
+235,916
New +$6.64M 0.06% 54
2018
Q2 		– Sell
-100,000
Closed -$4.2M – 121
2018
Q1 		$4.2M Hold
100,000
– – 0.04% 81
2017
Q4 		$2.48M Hold
100,000
– – 0.02% 95
2017
Q3 		$2.28M Hold
100,000
– – 0.02% 95
2017
Q2 		$2.3M Buy
+100,000
New +$1.96M 0.02% 81
2016
Q3 		– Sell
-118,963
Closed -$17.3M – 137
2016
Q2 		$17.3M Hold
118,963
– – 0.18% 35
2016
Q1 		$12.3M Buy
118,963
+9,179
+8% +$985K 0.13% 50
2015
Q4 		$18.4M Hold
109,784
– – 0.15% 45
2015
Q3 		$15.5M Buy
109,784
+12,500
+13% +$2.8M 0.14% 49
2015
Q2 		$21.7M Hold
97,284
– – 0.19% 45
2015
Q1 		$16.1M Buy
97,284
+36,116
+59% +$5.86M 0.13% 49
2014
Q4 		$7.25M Hold
61,168
– – 0.07% 59
2014
Q3 		$5.1M Hold
61,168
– – 0.06% 62
2014
Q2 		$5.65M Hold
61,168
– – 0.07% 64
2014
Q1 		$5.54M Sell
61,168
-3,178
-5% -$355K 0.07% 67
2013
Q4 		$6.59M Sell
64,346
-21,500
-25% -$1.52M 0.09% 56
2013
Q3 		$5.41M Buy
+85,846
New +$4.83M 0.08% 56

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Baker Bros. Advisors's NVAX Position: Q2 2022 in Review

Baker Bros. Advisors sold out of Novavax (NVAX) in Q2 2022, closing a stake of 48,168 shares — an estimated $3.55M sold.

Baker Bros. Advisors first reported a position in NVAX in Q3 2013 and held it in 26 quarters. The position peaked at $30.5M in Q2 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Baker Bros. Advisors reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Baker Bros. Advisors sold 48,168 Novavax shares in Q2 2022, an estimated $3.55M.
  • Baker Bros. Advisors first reported a position in Novavax in Q3 2013 and held it in 26 quarters.
  • Baker Bros. Advisors's Novavax position peaked at $30.5M in Q2 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Baker Bros. Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.